VC

Vivo Capital Portfolio holdings

AUM $977M
This Quarter Return
+36.8%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$706M
AUM Growth
+$706M
Cap. Flow
+$195M
Cap. Flow %
27.68%
Top 10 Hldgs %
75.21%
Holding
36
New
6
Increased
3
Reduced
5
Closed
2

Top Buys

1
VYNE icon
VYNE Therapeutics
VYNE
$151M
2
ASND icon
Ascendis Pharma
ASND
$26.2M
3
QTTB icon
Q32 Bio
QTTB
$21.7M
4
ARWR icon
Arrowhead Research
ARWR
$13.7M
5
CBAY
Cymabay Therapeutics
CBAY
$10.4M

Top Sells

1
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
$20.3M
2
AIMT
Aimmune Therapeutics, Inc.
AIMT
$10.7M
3
SBBP
Strongbridge Biopharma plc.
SBBP
$4.73M
4
CRSP icon
CRISPR Therapeutics
CRSP
$2.31M
5
KALA icon
KALA BIO
KALA
$1.83M

Sector Composition

1 Healthcare 95.38%
2 Materials 2.68%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VYNE icon
1
VYNE Therapeutics
VYNE
$8.16M
$151M 21.35% +4,011,236 New +$151M
ASND icon
2
Ascendis Pharma
ASND
$11.8B
$142M 20.07% 2,166,832 +400,000 +23% +$26.2M
BHVN
3
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$52.8M 7.48% 2,049,545 +72,727 +4% +$1.87M
CDXS icon
4
Codexis
CDXS
$246M
$33.6M 4.76% 3,054,825 – –
APLS icon
5
Apellis Pharmaceuticals
APLS
$3.48B
$32.2M 4.57% 1,457,834 – –
VRNA
6
Verona Pharma
VRNA
$9.16B
$29.9M 4.23% 1,492,951 – –
ACRS icon
7
Aclaris Therapeutics
ACRS
$209M
$28.9M 4.09% 1,647,214 – –
QTTB icon
8
Q32 Bio
QTTB
$20.9M
$21.7M 3.07% +1,159,742 New +$21.7M
NBRV
9
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$20.5M 2.9% 4,074,190 – –
AMRS
10
DELISTED
Amyris Inc.
AMRS
$18.9M 2.68% 2,826,711 – –
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$17.6M 2.5% 1,791,257 – –
SBBP
12
DELISTED
Strongbridge Biopharma plc.
SBBP
$17M 2.4% 1,918,132 -534,265 -22% -$4.73M
KALA icon
13
KALA BIO
KALA
$78.8M
$16.5M 2.34% 1,043,020 -115,891 -10% -$1.83M
KDMN
14
DELISTED
Kadmon Holdings, Inc.
KDMN
$14.2M 2.01% 3,333,333 – –
ARWR icon
15
Arrowhead Research
ARWR
$3.05B
$13.7M 1.94% +1,900,000 New +$13.7M
RNAC icon
16
Cartesian Therapeutics
RNAC
$261M
$11.4M 1.62% 1,119,189 – –
CBAY
17
DELISTED
Cymabay Therapeutics
CBAY
$10.4M 1.47% +800,000 New +$10.4M
AIMT
18
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$9.77M 1.38% 306,872 -336,754 -52% -$10.7M
GNCA
19
DELISTED
Genocea Biosciences, Inc.
GNCA
$8.59M 1.22% +8,180,000 New +$8.59M
SLNO icon
20
Soleno Therapeutics
SLNO
$3.6B
$7.31M 1.04% 4,033,534 – –
AUPH icon
21
Aurinia Pharmaceuticals
AUPH
$1.58B
$6.3M 0.89% 1,213,290 – –
ZLAB icon
22
Zai Lab
ZLAB
$3.68B
$6.06M 0.86% 283,787 -33,780 -11% -$721K
SRRA
23
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$5.05M 0.72% 2,438,270 – –
RGNX icon
24
Regenxbio
RGNX
$451M
$4.91M 0.7% 164,403 – –
FOMX
25
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$4.39M 0.62% 855,000 – –
1
2